Most, at an estimated 2 million-plus new cases each year, are basal-cell and squamous-cell skin cancers. ❋ Unknown (2011)
The Swiss group said a phase II study of vismodegib showed positive results in people with advanced basal-cell carcinoma as the tests met the primary endpoint of showing the drug shrank tumors in a pre-defined percentage of people. ❋ Goran Mijuk (2011)
Erivedge is meant for use in patients with locally advanced basal-cell cancer who aren't candidates for surgery or radiation. ❋ Jennifer Corbett Dooren (2012)
For instance, he says, some cancer-insurance plans exclude skin cancer entirely, while others won't cover basal-cell skin cancer, the most common kind. ❋ Jessica Silver-Greenberg (2011)
The FDA said Erivedge is the first FDA-approved drug for metastatic basal-cell carcinoma. ❋ Jennifer Corbett Dooren (2012)
The study showed tumors shrank in 43% patients, or 27 out of 63, with locally advanced basal-cell cancer. ❋ Jennifer Corbett Dooren (2012)
The drug's approval was based on a study involving 96 patients with locally advanced or metastatic basal-cell carcinoma. ❋ Jennifer Corbett Dooren (2012)
Estimates are that as many as three million people are diagnosed with basal-cell carcinoma world-wide each year, including two million in the U.S. The cancer starts in the top layer of skin. ❋ Jennifer Corbett Dooren (2012)
In adults the pathway is less active, but in recent years, researchers have linked its malfunction—due to mutations and other mechanisms—to several cancers, including basal-cell carcinoma and a rare brain tumor that generally affects children called medulloblastoma. ❋ Jennifer Corbett Dooren (2012)
The Food and Drug Administration approved a new type of drug developed by the U.S. unit of Roche Holding AG to treat advanced cases of basal-cell skin cancer, the most common type of skin cancer. ❋ Jennifer Corbett Dooren (2012)
In February 2007, at the age of sixty, he was reaping the consequences of a lifelong disdain of hats and sunscreen: he had a half-dollar-sized basal-cell carcinoma on the back of his head and his dermatologist wanted to take it off.9 ❋ MARYN MCKENNA (2010)
So is the basal-cell carcinoma the AP says he was treated for in February. ❋ Unknown (2009)
Blocking UVB helps reduce sunburn and protect against the more common (but far less deadly) forms of skin cancer called squamous and basal-cell carcinoma. ❋ Unknown (2008)
But the only concession I made after my basal-cell diagnosis was to cover my face as I sunbathed in secret. ❋ Unknown (2008)
But even if you don't get burned, skin experts say UVA rays 'deep penetration into the skin causes genetic damage and increases the risk of squamous-cell, basal-cell and malignant melanoma, the most serious type of skin cancer. ❋ Unknown (2008)
Enlarged (non-cancerous) prostate; basal-cell carcinoma (skin cancer) on the nose; colon cancer (treatment for which removed two feet of his colon); colonic polyps; partial hearing loss in both ears; a collapsed lung (after the 1981 assassination attempt); severe nearsightedness. ❋ Unknown (2005)
